Revenue: The sum of all revenue fields included for a company's operating activities.
Bio-Rad Laboratories, Inc. (BIO) had Revenue of $651.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$651.00M |
$371.40M |
|
$305.20M |
|
$345.80M |
|
$578.40M |
|
$72.60M |
|
$469.50M |
|
$542.10M |
|
$84.10M |
|
$371.40M |
|
$371.40M |
|
$371.40M |
|
$-230.82M |
|
$72.60M |
|
$72.60M |
|
26.75M |
|
26.81M |
|
$13.89 |
|
$13.85 |
|
| Balance Sheet Financials | |
$3.02B |
|
$517.90M |
|
$7.23B |
|
$10.25B |
|
$961.30M |
|
$803.00M |
|
$2.12B |
|
$3.08B |
|
$7.17B |
|
$6.44B |
|
$7.17B |
|
26.74M |
|
| Cash Flow Statement Financials | |
$206.80M |
|
$-159.90M |
|
$-71.60M |
|
$532.20M |
|
$518.80M |
|
$-13.40M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.14 |
|
-- |
|
-- |
|
0.10 |
|
0.17 |
|
53.12% |
|
11.15% |
|
11.15% |
|
-- |
|
83.27% |
|
57.05% |
|
$144.80M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.39 |
|
1.47 |
|
61.08 |
|
5.18% |
|
5.77% |
|
3.62% |
|
4.66% |
|
$268.30 |
|
$5.40 |
|
$7.71 |
|